Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113817693A reveals a breakthrough PpYSDR mutant for testosterone synthesis, offering superior yield and greener manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN119528983B reveals asymmetric alkylaluminum catalysis for high-purity gamma-ketophosphine oxide manufacturing with reduced heavy metal contamination.
Novel condensation method for Edoxaban intermediate ensures high purity and cost efficiency. Ideal for reliable pharmaceutical intermediate supplier partnerships and scalable production.
Patent CN117756767A reveals metal-free photoredox method for fluorinated aldehydes. Enables cost reduction and supply chain reliability for complex pharmaceutical intermediates manufacturing globally.
Patent CN106632014B reveals a high-yield synthesis of 2-amino-5-chloropyridine using ionic liquids. Discover cost-effective manufacturing and supply chain advantages.
Patent CN114591228B details Pd-catalyzed kinetic resolution for high-purity chiral sulfoxides. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112390815B details a high-yield d-biotin process. Achieve >99% purity and eliminate phosgene risks for reliable vitamin manufacturing.
Patent CN111362782B reveals a greener route to m-trifluoromethylphenol using recyclable ionic liquids, offering safer conditions and reduced waste for pharmaceutical intermediates.
Novel visible-light synthesis of fluoroalkyl indolines using Eosin Y. Green chemistry, mild conditions, high yield for pharmaceutical intermediates.
Patent CN116969987A reveals green chitosan-copper catalysis for quinoline silylation. Achieve cost reduction in pharmaceutical intermediates manufacturing with recyclable systems.
Patent CN110467571A details a low-cost synthesis for URAT1 inhibitor intermediates. This method ensures high purity and supply chain stability for global pharmaceutical manufacturing.
Patent CN103724264A details iridium-catalyzed asymmetric hydrogenation for high-purity chiral tetrahydroisoquinoline derivatives, offering significant cost reduction and supply chain reliability.
Patent CN105755095B details enzymatic synthesis of chiral hydroxy acids. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102260721A details a green enzymatic route for Levetiracetam intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN1778889A details high-purity S-CHBE production via Aureobasidium pullulans. This method offers significant cost reduction and supply chain reliability for global buyers.
Patent CN115490732B discloses a novel one-pot synthesis for chiral biphenyl diol selenium sulfide catalysts offering mild conditions and cost-effective manufacturing for fine chemical intermediates.
Patent CN104651243B details high-yield biocatalytic synthesis of (R)-1,3-butanediol. Offers superior purity and cost-effective supply chain solutions for antibiotic manufacturing.
Patent CN109762768B details a novel Bacillus B8W22 strain for producing high-purity pharmaceutical intermediates with superior stereoselectivity and reduced environmental impact.
Patent CN115368218B reveals a zinc-catalyzed route for 4-diarylmethyl phenols. Achieves high selectivity and yield, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112110801B details a cost-effective nickel-catalyzed method for gamma-aryl ketones, offering significant supply chain advantages for pharmaceutical intermediate manufacturing.